WHO is concerned over insufficient access to insulin

The World Health Organization (WHO) described as alarming the insufficient access to insulin worldwide, the main issue of the World Diabetes Day being celebrated on Sunday.
In its last report, WHO indicated that high prices, scarce insulin availability, the fact that a few producers control the insulin market and poor health systems are the main hurdles to universal access.
Insulin is the basis of diabetes treatment: it turns a deadly disease into a treatable one for 9 million people with type 1 diabetes.
For over 60 million people with type 2 diabetes, this medicine is essential to reduce the risk of kidney failure, blindness and limb amputation.
The report highlights that, although 3 in 4 people with type 2 diabetes live in countries other than North America and Europe, they make up less than 40 percent regarding insulin sales income.